
zzso aiming to block immune suppression with zzso zzso zzso zzso zzso zzso is a recently clinically established strategy to enhance immune driven zzso zzso To be successful, this approach depends on the existence of a suppressed immune response against the tumor that can be released by the treatment or alternatively needs to be combined with an zzso zzso A zzso zzso zzso fusion protein zzso the strong zzso zzso property of bacterial zzso in concert with the tumor cell binding capacity in zzso zzso Our purpose was to investigate the feasibility of combining zzso with zzso therapy against the poorly zzso zzso mouse melanoma tumor zzso with the human zzso zzso zzso recognized by the zzso zzso zzso zzso tumors growing in the lung were completely insensitive to zzso zzso zzso treatment of the zzso tumors induced strong zzso and targeting of both zzso and zzso T zzso In zzso zzso regulatory T cells accumulated in the zzso Combining zzso with zzso and zzso showed greatly enhanced zzso effects and prolonged long-term zzso In zzso when the expansion of regulatory T cells was zzso the number of specific zzso T cells was enhanced and the zzso zzso activity was significantly zzso zzso these data emphasize the potential of combining cancer treatment using zzso zzso zzso with zzso zzso and directed killing by zzso zzso 

